
Bloomberg
Apr 13, 2023 - 6 min
With court rulings simultaneously revoking and approving a key abortion drug, how can pharma companies navigate the abortion access landscape? Aaron Gregg and Christopher Rowland discuss the legal uncertainty these companies now face.
If you want all the articles from The Washington Post click here to subscribe.